FIELD: medicine.
SUBSTANCE: invention refers to ophthalmology and can be used in surgery of subretinal haemorrhages combined with age-specific macular dystrophy with subretinal neovascular membrane. The technique involves subtotal vitrectomy and removal of posterior hyaloid membrane. Bevacizumab and Ranibizumab are injected intravitreally. It is followed with intravitreal injection of tissue plasminogen activator and expanding gas while a patient is pronated.
EFFECT: method allows deploying blood from under retina, ensuring pathogenetic action on haemorrhage source, preventing proliferative processes in vitreal cavity.
2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR SURGICAL MANAGEMENT OF SUBRETINAL HEMORRHAGES | 2018 |
|
RU2696923C1 |
METHOD OF TREATING MASSIVE SUBMACULAR HAEMORRHAGES ACCOMPANYING AGE-RELATED MACULAR DEGENERATION | 2019 |
|
RU2696056C1 |
SURGICAL METHOD FOR TREATING THE CASES OF SUBRETINAL NEOVASCULARIZATION DEVELOPED ON THE BACKGROUND OF CENTRAL RETINAL DYSTROPHY | 2003 |
|
RU2253420C1 |
TREATMENT METHOD OF AGE-RELATED MACULAR DEGENERATION | 2008 |
|
RU2368359C1 |
METHOD FOR APPLYING SURGICAL REMOVAL AND PHOTODYNAMIC PROPHYLAXIS OF RECURRENT SUBRETINAL NEOVASCULAR MEMBRANES | 2003 |
|
RU2243748C1 |
METHOD OF SURGICAL TREATMENT OF THE CICATRICAL STAGE OF THE SUBRETINAL NEOVASCULAR MEMBRANE | 2017 |
|
RU2647803C1 |
METHOD OF TREATMENT OF CHOROIDAL NEOVASCULATION | 2018 |
|
RU2676075C1 |
SURGICAL METHOD FOR APPLYING PHOTODYNAMIC TREATMENT TO SUBRETINAL NEOVASCULAR MEMBRANES | 2003 |
|
RU2253418C1 |
METHOD FOR DETERMINING TACTICS OF TREATING PATIENTS WITH WET FORM OF AGE-RELATED MACULAR DEGENERATION | 2015 |
|
RU2612835C1 |
METHOD OF TREATMENT OF SUBRETINAL NEOVASCULATION | 2006 |
|
RU2334495C1 |
Authors
Dates
2009-09-10—Published
2008-04-29—Filed